| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |